353 related articles for article (PubMed ID: 20194728)
1. Aromatase deficiency inhibits the permeability transition in mouse liver mitochondria.
Moro L; Arbini AA; Hsieh JT; Ford J; Simpson ER; Hajibeigi A; Oz OK
Endocrinology; 2010 Apr; 151(4):1643-52. PubMed ID: 20194728
[TBL] [Abstract][Full Text] [Related]
2. Estrogen replacement reverses the hepatic steatosis phenotype in the male aromatase knockout mouse.
Hewitt KN; Pratis K; Jones ME; Simpson ER
Endocrinology; 2004 Apr; 145(4):1842-8. PubMed ID: 14684602
[TBL] [Abstract][Full Text] [Related]
3. Chemosensitization by knockdown of adenine nucleotide translocase-2.
Le Bras M; Borgne-Sanchez A; Touat Z; El Dein OS; Deniaud A; Maillier E; Lecellier G; Rebouillat D; Lemaire C; Kroemer G; Jacotot E; Brenner C
Cancer Res; 2006 Sep; 66(18):9143-52. PubMed ID: 16982757
[TBL] [Abstract][Full Text] [Related]
4. A selective estrogen receptor α agonist ameliorates hepatic steatosis in the male aromatase knockout mouse.
Chow JD; Jones ME; Prelle K; Simpson ER; Boon WC
J Endocrinol; 2011 Sep; 210(3):323-34. PubMed ID: 21705395
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial ATP transporter depletion protects mice against liver steatosis and insulin resistance.
Cho J; Zhang Y; Park SY; Joseph AM; Han C; Park HJ; Kalavalapalli S; Chun SK; Morgan D; Kim JS; Someya S; Mathews CE; Lee YJ; Wohlgemuth SE; Sunny NE; Lee HY; Choi CS; Shiratsuchi T; Oh SP; Terada N
Nat Commun; 2017 Feb; 8():14477. PubMed ID: 28205519
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice.
Nemoto Y; Toda K; Ono M; Fujikawa-Adachi K; Saibara T; Onishi S; Enzan H; Okada T; Shizuta Y
J Clin Invest; 2000 Jun; 105(12):1819-25. PubMed ID: 10862797
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial alterations in livers of Sod1-/- mice fed alcohol.
Kessova IG; Cederbaum AI
Free Radic Biol Med; 2007 May; 42(10):1470-80. PubMed ID: 17448893
[TBL] [Abstract][Full Text] [Related]
8. Carboxyatractyloside effects on brown-fat mitochondria imply that the adenine nucleotide translocator isoforms ANT1 and ANT2 may be responsible for basal and fatty-acid-induced uncoupling respectively.
Shabalina IG; Kramarova TV; Nedergaard J; Cannon B
Biochem J; 2006 Nov; 399(3):405-14. PubMed ID: 16831128
[TBL] [Abstract][Full Text] [Related]
9. tBid interaction with cardiolipin primarily orchestrates mitochondrial dysfunctions and subsequently activates Bax and Bak.
Gonzalvez F; Pariselli F; Dupaigne P; Budihardjo I; Lutter M; Antonsson B; Diolez P; Manon S; Martinou JC; Goubern M; Wang X; Bernard S; Petit PX
Cell Death Differ; 2005 Jun; 12(6):614-26. PubMed ID: 15818416
[TBL] [Abstract][Full Text] [Related]
10. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
Nocito A; Dahm F; Jochum W; Jang JH; Georgiev P; Bader M; Renner EL; Clavien PA
Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of bicyclol on tetracycline-induced fatty liver in mice.
Yu HY; Wang BL; Zhao J; Yao XM; Gu Y; Li Y
Toxicology; 2009 Jul; 261(3):112-8. PubMed ID: 19427351
[TBL] [Abstract][Full Text] [Related]
12. Role of the mitochondrial membrane permeability transition in cell death.
Tsujimoto Y; Shimizu S
Apoptosis; 2007 May; 12(5):835-40. PubMed ID: 17136322
[TBL] [Abstract][Full Text] [Related]
13. The hepatoprotective effects of adenine nucleotide translocator-2 against aging and oxidative stress.
Kim HS; Je JH; Son TG; Park HR; Ji ST; Pokharel YR; Jeon HM; Kang KW; Kang HS; Chang SC; Kim HS; Chung HY; Lee J
Free Radic Res; 2012 Jan; 46(1):21-9. PubMed ID: 22034909
[TBL] [Abstract][Full Text] [Related]
14. Indirubin and NAD
Teodoro JS; Varela AT; Duarte FV; Gomes AP; Palmeira CM; Rolo AP
Eur J Clin Invest; 2018 Jun; 48(6):e12932. PubMed ID: 29603199
[TBL] [Abstract][Full Text] [Related]
15. The methyl donor S-adenosylmethionine prevents liver hypoxia and dysregulation of mitochondrial bioenergetic function in a rat model of alcohol-induced fatty liver disease.
King AL; Mantena SK; Andringa KK; Millender-Swain T; Dunham-Snary KJ; Oliva CR; Griguer CE; Bailey SM
Redox Biol; 2016 Oct; 9():188-197. PubMed ID: 27566282
[TBL] [Abstract][Full Text] [Related]
16. Caspase-dependent alteration of the ADP/ATP translocator triggers the mitochondrial permeability transition which is not required for the low-potassium-dependent apoptosis of cerebellar granule cells.
Atlante A; Bobba A; de Bari L; Fontana F; Calissano P; Marra E; Passarella S
J Neurochem; 2006 May; 97(4):1166-81. PubMed ID: 16606362
[TBL] [Abstract][Full Text] [Related]
17. Hypoxic preconditioning-induced mitochondrial protection is not disrupted in a cell model of mtDNA T8993G mutation-induced F1F0-ATP synthase defect: the role of mitochondrial permeability transition.
Huang WY; Jou MJ; Peng TI
Free Radic Biol Med; 2014 Feb; 67():314-29. PubMed ID: 24291231
[TBL] [Abstract][Full Text] [Related]
18. The role of cyclophilin D in interspecies differences in susceptibility to hepatotoxic drug-induced mitochondrial injury.
Sekine S; Kimura T; Motoyama M; Shitara Y; Wakazono H; Oida H; Horie T
Biochem Pharmacol; 2013 Nov; 86(10):1507-14. PubMed ID: 24012842
[TBL] [Abstract][Full Text] [Related]
19. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore.
Kokoszka JE; Waymire KG; Levy SE; Sligh JE; Cai J; Jones DP; MacGregor GR; Wallace DC
Nature; 2004 Jan; 427(6973):461-5. PubMed ID: 14749836
[TBL] [Abstract][Full Text] [Related]
20. The mitochondrial adenine nucleotide transporters in myogenesis.
Flierl A; Schriner SE; Hancock S; Coskun PE; Wallace DC
Free Radic Biol Med; 2022 Aug; 188():312-327. PubMed ID: 35714845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
